1. Market Research
  2. > Cancer
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

Publication dates

Publishers

  • All
    • ICON Group
9 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

The 2021-2026 World Outlook for Lymphoma Therapeutics

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for lymphoma therapeutics across more than ## countries.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Demand

The 2021-2026 World Outlook for Non-Hodgkin Lymphoma (NHL) Therapeutics

  • $ 995
  • November 2019
  • 304 pages

The 2021-2026 World Outlook for Non-Hodgkin Lymphoma (NHL) Therapeutics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • Demand

The 2021-2026 World Outlook for Nuclear Medicine Diagnostic Positron Emission Tomography (PET) and Single-Photon Emission Computerized Tomography (SPECT) Technologies

  • $ 995
  • November 2019
  • 334 pages

lymphoma, thyroid, neurological, and oncological diagnostics and studies, irrespective of product packaging, formulation, size, or form.

  • Diagnostic Imaging
  • Lymphoma
  • World
  • Demand

The 2021-2026 World Outlook for Hematological Cancer Treatments

  • $ 995
  • November 2019
  • 300 pages

Given this caveat, in this report we define the sales of hematological cancer treatments as including all commonly understood products and/ or services falling within this broad category, such as treatments for leukemia, lymphoma, and myeloma, targeted drugs, selective, orally administe

  • Cancer
  • Lymphoma
  • World
  • Demand

The 2021-2026 World Outlook for Radioisotopes

  • $ 995
  • November 2019
  • 299 pages

lymphoma, thyroid, and neurological treatments, irrespective of product packaging, formulation, size, or form.

  • Diagnostic Imaging
  • Lymphoma
  • World
  • Demand

The 2021-2026 World Outlook for Non-Small Cell Lung Cancer (NSCLC) Drugs

  • $ 995
  • November 2019
  • 301 pages

Given this caveat, in this report we define the sales of non-small cell lung cancer (NSCLC) drugs as including all commonly understood products falling within this broad category, such as chemotherapies, epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) inhibitors

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • Demand

The 2021-2026 World Outlook for Hematological Disorder Drugs and Diagnostics

  • $ 995
  • November 2019
  • 306 pages

Given this caveat, in this report we define the sales of hematological disorder drugs and diagnostics as including all commonly understood products falling within this broad category, such as systems developed for treatment of hematological diseases and cancers, tests for leukemia,

  • Lymphoma
  • Pathology
  • World
  • Demand

The 2021-2026 World Outlook for Nuclear Medicine Diagnostics

  • $ 995
  • November 2019
  • 300 pages

lymphoma, thyroid, neurology, and oncology, irrespective of product packaging, formulation, size, or form.

  • Diagnostic Imaging
  • Lymphoma
  • World
  • Demand

The 2021-2026 World Outlook for Nuclear Medicine Therapeutics

  • $ 995
  • November 2019
  • 300 pages

lymphoma, and endocrine tumor medical issues, irrespective of product packaging, formulation, size, or form.

  • Lymphoma
  • Therapy
  • World
  • Demand


View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on